Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 145
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification 2021 Urso L.Silic-Benussi M.Bonanno L.Lunardi F.Guarneri V.Calabrese F.Rea F.Conte P.Pasello G. + CYTOKINE - -
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 2021 Dal Maso, ALorenzi, MFerro, AScattolin, DIndraccolo, SFrega, SMenis, JBonanno, LCalabrese, FGuarneri, VConte, PPasello, G + FUTURE ONCOLOGY - -
Skip pattern approach toward the early access of innovative anticancer drugs. 2021 G Pasello + ESMO OPEN - -
Diagnostic challenges in epithelioid pleural mesothelioma: Case series with support from electron microscopy 2021 Fortarezza F.Della Barbera M.Pezzuto F.Lunardi F.Faccioli E.Pasello G.Rea F.Rizzo S.Calabrese F. DIAGNOSTICS - -
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment 2021 Pezzuto, FedericaLunardi, FrancescaVedovelli, LucaFortarezza, FrancescoUrso, LoredanaFaccioli, EleonoraSchiavon, MarcoGregori, DarioRea, FedericoPasello, GiuliaCalabrese, Fiorella + FRONTIERS IN ONCOLOGY - -
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM) 2021 G Pasello + ESMO OPEN - -
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report 2021 Ferro A.Pasello G.Guarneri V.Conte P.Alaibac M.Bonanno L. + FRONTIERS IN MEDICINE - -
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 2021 Lorenzi, M.Dal Maso, A.Ferro, A.Scattolin, D.Indraccolo, S.Frega, S.Menis, J.Bonanno, L.Guarneri, V.Conte, P. F.Pasello, G. + JOURNAL OF THORACIC ONCOLOGY - -
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 2021 Dal Maso, A.Ferro, A.Pretelli, G.Frega, S.Menis, J.Pasello, G.Guarneri, V.Conte, P. F.Bonanno, L. + JOURNAL OF THORACIC ONCOLOGY - -
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Bonanno, L.Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
The rarest of rare thymic lesions: A 10-year surgical pathology experience 2021 Calabrese F.Fortarezza F.Pezzuto F.Lunardi F.Comacchio G.Sbaraglia M.Pasello G.Marulli G.Dei Tos A. P.Rea F. CANCERS - -
Computed Tomography and Spirometry Can Predict Unresectability in Malignant Pleural Mesothelioma 2021 Alice BelliniAndrea Dell'AmoreChiara GiraudoAntonella ModugnoNicol BernardinelloStefano TerziGiovanni ZambelloGiulia PaselloAndrea ZuinFederico Rea JOURNAL OF CLINICAL MEDICINE - -
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 2021 Lorenzi, MartinaFerro, AlessandraScattolin, DanielaDal Maso, AlessandroIndraccolo, StefanoCalabrese, FiorellaBonanno, LauraConte, PierFrancoGuarneri, ValentinaPasello, Giulia + THE ONCOLOGIST - -
Lobectomy with artery reconstruction and pneumonectomy for NSCLC: a propensity score weighting study 2021 Schiavon, MarcoComacchio, Giovanni MariaMammana, MarcoFaccioli, EleonoraStocca, FrancescaGregori, DarioLorenzoni, GiuliaZuin, AndreaPasello, GiuliaCalabrese, FiorellaDell'Amore, AndreaRea, Federico + ANNALS OF THORACIC SURGERY - -
Immunotherapy in malignant pleural mesothelioma: a review of literature data. 2021 Giulia Pasello + TRANSLATIONAL LUNG CANCER RESEARCH - -
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial 2021 Grossi F.Pasello G. + ESMO OPEN - -
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practice 2021 Bonanno L.Pasello G.Rea F.Guarneri V.Conte P. + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
realpse patterns and tailored treatment strategies for malignant pleural mesothelioma recurrence after multimodality therapy 2021 Andrea Dell'AmoreAndrea ZuinGiulia PaselloFiorella CalabreseMarco SchiavonFederico Rea + JOURNAL OF CLINICAL MEDICINE - -
Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model 2021 Buja, AlessandraRivera, MicheleScioni, ManuelaPasello, GiuliaRebba, VincenzoSchiavon, MarcoCalabrese, FiorellaBaldo, VincenzoConte, PierFranco + THORACIC CANCER - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, StefanoBonanno, Laura + TRANSLATIONAL LUNG CANCER RESEARCH - -
Mostrati risultati da 41 a 60 di 145
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile